REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $675,000 | -79.4% | 261,616 | -63.4% | 0.23% | -67.2% |
| Q3 2021 | $3,276,000 | -51.0% | 715,293 | -26.3% | 0.69% | -72.1% |
| Q2 2021 | $6,680,000 | -58.8% | 970,936 | -56.2% | 2.48% | -55.4% |
| Q1 2021 | $16,227,000 | +6.1% | 2,216,793 | +17.1% | 5.57% | -8.7% |
| Q4 2020 | $15,292,000 | -20.2% | 1,892,593 | +0.9% | 6.10% | -39.6% |
| Q3 2020 | $19,169,000 | +53.0% | 1,875,601 | +0.3% | 10.09% | +69.6% |
| Q2 2020 | $12,529,000 | +49.5% | 1,870,000 | +1.1% | 5.95% | -29.5% |
| Q1 2020 | $8,380,000 | -73.8% | 1,850,000 | -64.8% | 8.44% | +4165.2% |
| Q4 2019 | $31,929,000 | +144.2% | 5,260,185 | +183.3% | 0.20% | -76.0% |
| Q3 2019 | $13,074,000 | +7.7% | 1,857,068 | -0.5% | 0.82% | -16.9% |
| Q2 2019 | $12,136,000 | +49.6% | 1,867,000 | +91.3% | 0.99% | +37.3% |
| Q1 2019 | $8,110,000 | +55.6% | 975,928 | +3.9% | 0.72% | -14.9% |
| Q4 2018 | $5,212,000 | +12.0% | 939,014 | +78.2% | 0.85% | -67.2% |
| Q3 2018 | $4,653,000 | +9.1% | 527,000 | +5.4% | 2.58% | +6.8% |
| Q2 2018 | $4,265,000 | +83.6% | 500,000 | +10.9% | 2.42% | +26.5% |
| Q1 2018 | $2,323,000 | +1.7% | 451,000 | +1.5% | 1.91% | +44.3% |
| Q4 2017 | $2,284,000 | – | 444,301 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |